Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent
Open Access
- 1 February 1991
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 53 (2) , 399-402
- https://doi.org/10.1093/ajcn/53.2.399
Abstract
G L Klein, A C Alfrey, M Shike, D J Sherrard; Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent,Keywords
This publication has 26 references indexed in Scilit:
- Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.Journal of Clinical Investigation, 1987
- Response to aluminum in parenteral nutrition during infancyThe Journal of Pediatrics, 1986
- ALUMINIUM CONTAMINATION OF INTRAVENOUS PHARMACEUTICALS, NUTRIENTS, AND BLOOD PRODUCTSThe Lancet, 1986
- Aluminum Does Not Accumulate in Teenagers and Adults on Prolonged Parenteral Nutrition Containing Free Amino AcidsJournal of Parenteral and Enteral Nutrition, 1986
- Evidence of Aluminum Loading in Infants Receiving Intravenous TherapyNew England Journal of Medicine, 1985
- Inadvertent Aluminum Administration during Plasma Exchange Due to Aluminum Contamination of Albumin-Replacement SolutionsNew England Journal of Medicine, 1985
- Encephalopathy in childhood secondary to aluminum toxicityThe Journal of Pediatrics, 1984
- The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol TherapyNew England Journal of Medicine, 1982
- Reversal of Aluminum-Induced Hemodialysis Anemia by a Low-Aluminum DialysateNew England Journal of Medicine, 1982
- BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITIONThe Lancet, 1980